Status:

COMPLETED

Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography

Lead Sponsor:

St. Luke's-Roosevelt Hospital Center

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This protocol details a novel myocardial perfusion Single Photon Emission Computed Tomography (SPECT) protocol wherein patients receive a low-dose (6 mCi) of Tc-99m sestamibi during exercise or regade...

Detailed Description

Specific Aims: To validate acceptable image quality and the stress/rest myocardial count density ratio (as defined below) of the Rapid Stress/Rest Protocol Experimental Design and Methods: Validati...

Eligibility Criteria

Inclusion

  • adult
  • not pregnant
  • suspected coronary artery disease

Exclusion

  • pregnant
  • under 18 years of age

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT01434641

Start Date

July 1 2011

End Date

March 1 2012

Last Update

April 11 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

'St. Luke's-Roosevelt Hospital

New York, New York, United States, 10025